Rampex Labs DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Default Key Product, Service and Excipients

Immunome's Desmoid Tumor Treatment Triumphs in Phase 3

16 Dec 2025

// FIERCE BIOTECH

Argenx Updates Uplight Studies in Thyroid Eye Disease

16 Dec 2025

// GLOBENEWSWIRE

FDA Approves AZ/Daiichi's Enhertu in 1st-Line Breast Cancer

16 Dec 2025

// BUSINESSWIRE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Global ChemShow

Not Confirmed

Book a meeting

envelop Contact Supplier

ACTIVE PHARMA INGREDIENTS

6 All APIs, 2 USDMF, 2 CEP/COS, 1 EU WC, 4 Listed APIs

6 All APIs
2 USDMF
2 CEP/COS
1 EU WC
4 Listed APIs

INTERMEDIATES

87 All Intermediates

87 All Intermediates

KEY PRODUCTS

22246-18-0, CAS 106261-49-8, CAS 1171331-39-7, CAS 119532-26-2, CAS 129722-34-5, CAS 130049-82-0, CAS 138564-58-6, CAS 152460-09-8, CAS 152460-10-1, CAS 179688-29-0, CAS 183322-17-0, CAS 183322-18-1, CAS 211915-84-3, CAS 212322-56-0, CAS 25333-42-0, CAS 41202-77-1, CAS 41263-74-5, CAS 42288-26-6, CAS 5464-78-8, CAS 55314-16-4, CAS 57260-71-6, CAS 641569-94-0, CAS 641569-96-2, CAS 641571-11-1, CAS 73942-87-7, CAS 749927-69-3, CAS 84163-13-3, Chlorzoxazone, Cinacalcet Hydrochloride, Olanzapine, Olanzapine Pamoate, Olanzapine Tartrate, Ondansetron Hydrochloride

Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

About

Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry.